Dr Julien Michel has collaborated with the software company Cresset under InnovateUK funding to integrate the open source software SOMD developed in his group for the past 7 years into Cresset's fully featured graphical user interface Flare, optimised for use in industry. SOMD is used to carry out Free Energy Perturbation calculations to predict compound activities of drug-like molecules ahead of expensive synthesis and bioactivity assays.
The School of Chemistry’s partnership with East Lothian-based SME Sunamp Ltd, which has resulted in the first commercialisation of domestic heat storage technology, has been highlighted in the Scottish Parliament’s debate on Scotland as a Science Nation.
Speaking in the debate, Richard Lochead MSP, Minister for Further Education, Higher Education and Science, described the Sunamp collaboration as an example of the great scientific work being carried out in Scotland:
Her first job will be to present her biocatalysis work at the EYCN 2020 event in Sitges, Spain in January. Over the next two years Shona will build networks with other young chemists from across Europe.
The project will use computational modelling techniques to predict new energetic materials with tailored properties.
Dr Olof Johansson and Prof. Euan Brechin recently organised a meeting on Photophysics of Molecular Magnets at the Royal Society of Edinburgh. The meeting brought together researchers from realted disciplines in chemistry and physics whose work often overlaps but who rarely have the chance to sattend the same conferences.
Dialysis technology company Invizius has secured funding from a consortium of investors including Mercia Asset Management and the University’s own venture investment fund, Old College Capital.
Invizius stems from years of research by Dr Andy Herbert and his team in the University’s School of Chemistry. In May 2018 he co-founded Invizius and became the Chief Technology Officer at the company.
The researchers believe they have found a way to reduce the risk of cardiovascular disease among patients undergoing long-term dialysis.
After applying on the recommendation of Professor Alison Hulme, I was fortunate enough to be selected for the Roche Continents programme. As a PhD student in Atmospheric Chemistry, I enjoy both science and arts and this was a perfect opportunity for me to explore creativity and the innovation process in both disciplines.
The Horrocks Group are once again extremely grateful for a donation made by Dr. Jim Love to support their research into neurodegenerative diseases. His previous gift helped to fund a single-molecule microscope that is currently being used to look at protein "clumps" that are formed in Alzheimer's and Parkinson's diseases. His second gift will be used to continue this important work, and will allow Owen Kantelberg, a second year Ph.D.